128 related articles for article (PubMed ID: 28757685)
1. Immunometabolism: Molecular Mechanisms, Diseases, and Therapies 2016.
Rosa Neto JC; Lira FS; Roy S; Festuccia W
Mediators Inflamm; 2017; 2017():8230298. PubMed ID: 28757685
[No Abstract] [Full Text] [Related]
2. "Bridge Proteins" Link Inflammation and Metabolic Diseases: Potential Targets for Therapeutics.
Jiang H; Qin G; Zhang X; Che D
Curr Protein Pept Sci; 2017; 18(6):619-629. PubMed ID: 27356936
[TBL] [Abstract][Full Text] [Related]
3. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
[TBL] [Abstract][Full Text] [Related]
4. Inflammation, metaflammation and immunometabolic disorders.
Hotamisligil GS
Nature; 2017 Feb; 542(7640):177-185. PubMed ID: 28179656
[TBL] [Abstract][Full Text] [Related]
5. The Immunometabolism Choreography.
Emambokus N; Granger A; Mott R; Helenius T
Cell Metab; 2017 Jul; 26(1):1. PubMed ID: 28683277
[No Abstract] [Full Text] [Related]
6. Foundations of Immunometabolism and Implications for Metabolic Health and Disease.
Hotamisligil GS
Immunity; 2017 Sep; 47(3):406-420. PubMed ID: 28930657
[TBL] [Abstract][Full Text] [Related]
7. NF-κB, inflammation, and metabolic disease.
Baker RG; Hayden MS; Ghosh S
Cell Metab; 2011 Jan; 13(1):11-22. PubMed ID: 21195345
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB signaling pathway and its therapeutic implications in human diseases.
Sarkar FH; Li Y; Wang Z; Kong D
Int Rev Immunol; 2008; 27(5):293-319. PubMed ID: 18853341
[TBL] [Abstract][Full Text] [Related]
9. The immunomodulating role of exercise in metabolic disease.
Lancaster GI; Febbraio MA
Trends Immunol; 2014 Jun; 35(6):262-9. PubMed ID: 24680647
[TBL] [Abstract][Full Text] [Related]
10. The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation.
Tornatore L; Thotakura AK; Bennett J; Moretti M; Franzoso G
Trends Cell Biol; 2012 Nov; 22(11):557-66. PubMed ID: 22995730
[TBL] [Abstract][Full Text] [Related]
11. NF-κβ signaling and chronic inflammatory diseases: exploring the potential of natural products to drive new therapeutic opportunities.
Killeen MJ; Linder M; Pontoniere P; Crea R
Drug Discov Today; 2014 Apr; 19(4):373-8. PubMed ID: 24246683
[TBL] [Abstract][Full Text] [Related]
12. Xenobiotic receptor meets NF-kappaB, a collision in the small bowel.
Xie W; Tian Y
Cell Metab; 2006 Sep; 4(3):177-8. PubMed ID: 16950133
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo.
Jimi E; Aoki K; Saito H; D'Acquisto F; May MJ; Nakamura I; Sudo T; Kojima T; Okamoto F; Fukushima H; Okabe K; Ohya K; Ghosh S
Nat Med; 2004 Jun; 10(6):617-24. PubMed ID: 15156202
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA Regulators of Anxiety and Metabolic Disorders.
Meydan C; Shenhar-Tsarfaty S; Soreq H
Trends Mol Med; 2016 Sep; 22(9):798-812. PubMed ID: 27496210
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory signal transduction from the Fc epsilon RI to NF-kappa B.
Klemm S; Ruland J
Immunobiology; 2006; 211(10):815-20. PubMed ID: 17113919
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies.
Gambhir S; Vyas D; Hollis M; Aekka A; Vyas A
World J Gastroenterol; 2015 Mar; 21(11):3174-83. PubMed ID: 25805923
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction via the NF-kappaB pathway: a targeted treatment modality for infection, inflammation and repair.
Ali S; Mann DA
Cell Biochem Funct; 2004; 22(2):67-79. PubMed ID: 15027095
[TBL] [Abstract][Full Text] [Related]
18. EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation.
Fusco F; Pescatore A; Conte MI; Mirabelli P; Paciolla M; Esposito E; Lioi MB; Ursini MV
Int Rev Immunol; 2015; 34(6):445-59. PubMed ID: 26269396
[TBL] [Abstract][Full Text] [Related]
19. Large-scale RNAi screens to dissect TNF and NF-κB signaling pathways.
Metzig M; Nickles D; Boutros M
Adv Exp Med Biol; 2011; 691():131-9. PubMed ID: 21153317
[No Abstract] [Full Text] [Related]
20. Oxysterols in Metabolic Syndrome: From Bystander Molecules to Bioactive Lipids.
Guillemot-Legris O; Mutemberezi V; Muccioli GG
Trends Mol Med; 2016 Jul; 22(7):594-614. PubMed ID: 27286741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
